Phenobarbital for the management of severe acute alcohol withdrawal (the PHENOMANAL trial): a pilot randomized controlled trial

Abstract Background Benzodiazepines are considered first-line treatment for patients experiencing severe acute alcohol withdrawal syndrome (sAAWS). Although several medications have been evaluated as potential adjuvant treatments for sAAWS, barbiturates show particular promise. Objective In the PHEN...

Descripción completa

Detalles Bibliográficos

Autores principales:	Niall Filewod, Stephen Hwang, Christian J. Turner, Leena Rizvi, Sara Gray, Michelle Klaiman, Danielle Buell, Johnathan Ailon, Alexander Caudarella, Galo F. Ginocchio, Marlene Santos, Gyan Sandhu, Norman Dewhurst, Kelly Sequeira, Karen E. A. Burns
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2022-01-01
Colección:	Pilot and Feasibility Studies
Materias:	Phenobarbital; Alcohol withdrawal Delirium tremens Treatment
Acceso en línea:	https://doi.org/10.1186/s40814-021-00963-4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!